Table 2.
Changes of lipid profiles after Xuezhikang treatment.
| Lipid profiles | Baseline | Aftertreatment | Percent change | P value | ||
|---|---|---|---|---|---|---|
| Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | |||
| TC, mmol/L | 5.54 (0.76) | 5.57 (4.93–6.07) | 4.96 (0.63) | 4.90 (4.44–5.96) | −10.5% | <0.001* |
| HDL-C, mmol/L | 1.07 (0.13) | 1.11 (0.95–1.18) | 1.19 (0.13) | 1.19 (1.12–1.30) | 11.2% | <0.001* |
| LDL-C, mmol/L | 3.35 (0.72) | 3.38 (2.85–3.98) | 2.86 (0.48) | 2.86 (2.51–3.12) | −14.6% | <0.001* |
| HDL-C/LDL-C ratio | 0.33 (0.07) | 0.30 (0.29–0.36) | 0.43 (0.07) | 0.43 (0.39–0.47) | 30.3% | <0.001* |
| TG, mmol/L | 3.32 (1.92) | 2.85 (2.16–3.97) | 2.21 (0.94) | 2.21 (1.39–2.80) | −22.5% | <0.001† |
SD: standard deviation; IQR: interquartile range; TC: total plasma cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglycerides.
*P values for paired t-test.
† P values for Wilcoxon signed rank test.